CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molden, T.
Right arrow Articles by Hagmar, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molden, T.
Right arrow Articles by Hagmar, B.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 367-372, February 2005
© 2005 American Association for Cancer Research

Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion

Tor Molden1, Irene Kraus1, Frank Karlsen3, Hanne Skomedal3, Jan F. Nygård2 and Bjørn Hagmar1

1 Institute of Pathology, National University Hospital; 2 Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway; and 3 NorChip AS, Klokkarstua, Norway

Requests for reprints: Tor Molden, Institute of Pathology, National University Hospital, Sognsveien 20, 0027 Oslo, Norway. Phone: 47-40403484; Fax: 011-47-32798801. E-mail: t.e.f.molden{at}labmed.uio.no

The purpose of this study was to compare the detection of human papillomavirus (HPV) DNA with detection of mRNA. The study included 4,136 women >30 years of age. E6/E7 mRNA expression from the carcinogenic HPV types 16, 18, 31, 33, and 45 was detected by the PreTect HPV-Proofer assay, whereas the presence of HPV DNA was detected by Gp5+/6+ consensus PCR followed by type-specific PCR. A total of 4.0% had an abnormal cytologic diagnosis, 3.0% were positive by PreTect HPV-Proofer, 4.4% by type-specific PCR, and 10.4% by consensus PCR. For detection of HPV in high-grade squamous intraepithelial lesion (HSIL), no significant difference was observed between PreTect HPV-Proofer and consensus PCR. For women with a cytologic normal, atypical squamous cell of uncertain significance, and low-grade SIL diagnosis, the detection rate of HPV was significantly higher by Gp5+/6+ consensus PCR (P < 0.005) than by PreTect HPV-Proofer. Histology confirmed 14 of 23 cytologic HSIL as cervical intraepithelial neoplasia grade >2. Of these women, PreTect HPV-Proofer and type-specific PCR detected 12, whereas consensus PCR detected 13. In conclusion, for HSIL, detection of E6/E7 transcripts from HPV types 16, 18, 31, 33, and 45 are present to the same degree as DNA detected by consensus PCR. Equally important, only a small proportion of the HPV DNA–positive women with a normal, atypical squamous cell of uncertain significance or low-grade SIL diagnosis had a detectable mRNA expression. HPV E6/E7 mRNA detection by PreTect HPV-Proofer represents a new promising test as an adjunct to cytology.




This article has been cited by other articles:


Home page
cellbioedHome page
K. Chamany, D. Allen, and K. Tanner
Making Biology Learning Relevant to Students: Integrating People, History, and Context into College Biology Teaching
CBE Life Sci Educ, September 1, 2008; 7(3): 267 - 278.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. A.V. Boulet, C. A.J. Horvath, S. Berghmans, and J. Bogers
Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 810 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C Horvath, G Boulet, S Sahebali, J Bogers, C Depuydt, A Vereecken, T Vermeulen, and D Vanden Broeck
Effects of fixation on RNA integrity in a liquid-based cervical cytology setting
J. Clin. Pathol., January 1, 2008; 61(1): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. E. Castle, J. Dockter, C. Giachetti, F. A.R. Garcia, M. K. McCormick, A. L. Mitchell, E. B. Holladay, and D. P. Kolk
A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer
Clin. Cancer Res., May 1, 2007; 13(9): 2599 - 2605.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
I. Kraus, T. Molden, R. Holm, A. K. Lie, F. Karlsen, G. B. Kristensen, and H. Skomedal
Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas
J. Clin. Microbiol., April 1, 2006; 44(4): 1310 - 1317.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.